摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5R,6R,7S,8S)-7,8-bis(benzyloxy)-5-[(benzyloxy)methyl]-5,6,7,8-tetrahydro-6-(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyloxy)imidazo[1,2-a]pyridine | 244036-98-4

中文名称
——
中文别名
——
英文名称
(5R,6R,7S,8S)-7,8-bis(benzyloxy)-5-[(benzyloxy)methyl]-5,6,7,8-tetrahydro-6-(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyloxy)imidazo[1,2-a]pyridine
英文别名
——
(5R,6R,7S,8S)-7,8-bis(benzyloxy)-5-[(benzyloxy)methyl]-5,6,7,8-tetrahydro-6-(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyloxy)imidazo[1,2-a]pyridine化学式
CAS
244036-98-4
化学式
C63H64N2O9
mdl
——
分子量
993.209
InChiKey
LBEAFUSKNHJDNO-RYGCAJFFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    11.58
  • 重原子数:
    74.0
  • 可旋转键数:
    25.0
  • 环数:
    10.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    100.89
  • 氢给体数:
    0.0
  • 氢受体数:
    11.0

反应信息

  • 作为反应物:
    描述:
    (5R,6R,7S,8S)-7,8-bis(benzyloxy)-5-[(benzyloxy)methyl]-5,6,7,8-tetrahydro-6-(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyloxy)imidazo[1,2-a]pyridinepalladium dihydroxide 氢气溶剂黄146 作用下, 以 甲醇乙酸乙酯 为溶剂, 反应 48.0h, 以69%的产率得到(5R,6R,7S,8S)-6-(β-D-glucopyranosyloxy)-5,6,7,8-tetrahydro-5-(hydroxymethyl)imidazo[1,2-a]pyridine-7,8-diol
    参考文献:
    名称:
    Inhibition of Cellobiohydrolases fromTrichoderma reesei. Synthesis and Evaluation of Some Glucose-, Cellobiose-, and Cellotriose-Derived Hydroximolactams andImidazoles
    摘要:
    The lactam 16, the hydroximolactams 8, 20, 23, and 27, and the imidazole 32 were prepared following known methods. They were tested together with the known tetrazole 35 and the hydroximolactams 2 and 36 as inhibitors of the cellobiohydrolases Cel7A and Cel6A from Trichoderma reesei. Cel7A is only weakly inhibited by these compounds. Comparing their inhibitory activity evidences the importance of occupying subsites tl and +2. We results strongly suggest that the shape of none of the variants of the lactone-type inhibitor motif embodied by these inhibitors is complementary to the subsite - 1, i.e.,analogous to the transition state. Cel6A is rather strongly inhibited by the cellobiose analogues 20, 23, and 32, and by the cellotriose analogue 27. Their relative inhibitory activities evidence that binding at subsite -2 depends upon the shape of the moiety occupying subsite - 1. There is only a small difference between the inhibition by the hydroximolactams 20 and 23, which may be (partially) protonated by the catalytic acid of either anti- or syn-protonating glycosidases, and the imidazole 32, which can only be protonated by anti-protonating glycosidases. The results strongly suggest that shape requirements must be met by glycosidase inhibitors before they can be used to characterize the proton trajectory of glycosidases.
    DOI:
    10.1002/(sici)1522-2675(19990707)82:7<963::aid-hlca963>3.0.co;2-v
  • 作为产物:
    参考文献:
    名称:
    Inhibition of Cellobiohydrolases fromTrichoderma reesei. Synthesis and Evaluation of Some Glucose-, Cellobiose-, and Cellotriose-Derived Hydroximolactams andImidazoles
    摘要:
    The lactam 16, the hydroximolactams 8, 20, 23, and 27, and the imidazole 32 were prepared following known methods. They were tested together with the known tetrazole 35 and the hydroximolactams 2 and 36 as inhibitors of the cellobiohydrolases Cel7A and Cel6A from Trichoderma reesei. Cel7A is only weakly inhibited by these compounds. Comparing their inhibitory activity evidences the importance of occupying subsites tl and +2. We results strongly suggest that the shape of none of the variants of the lactone-type inhibitor motif embodied by these inhibitors is complementary to the subsite - 1, i.e.,analogous to the transition state. Cel6A is rather strongly inhibited by the cellobiose analogues 20, 23, and 32, and by the cellotriose analogue 27. Their relative inhibitory activities evidence that binding at subsite -2 depends upon the shape of the moiety occupying subsite - 1. There is only a small difference between the inhibition by the hydroximolactams 20 and 23, which may be (partially) protonated by the catalytic acid of either anti- or syn-protonating glycosidases, and the imidazole 32, which can only be protonated by anti-protonating glycosidases. The results strongly suggest that shape requirements must be met by glycosidase inhibitors before they can be used to characterize the proton trajectory of glycosidases.
    DOI:
    10.1002/(sici)1522-2675(19990707)82:7<963::aid-hlca963>3.0.co;2-v
点击查看最新优质反应信息